Eiger BioPharmaceuticals, Inc., along with its four affiliates, filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the Northern District of Texas on April 1, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.4 USD | -10.11% | -40.00% | -64.37% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.37% | 3.95M | |
+1.63% | 42.75B | |
+47.70% | 41.61B | |
+12.02% | 41.34B | |
-8.83% | 26.59B | |
+6.46% | 25.49B | |
-23.37% | 18.12B | |
+30.02% | 12.24B | |
-2.44% | 11.76B | |
+7.94% | 11B |
- Stock Market
- Equities
- EIGR Stock
- News Eiger BioPharmaceuticals, Inc.
- Eiger BioPharmaceuticals, Inc. Filed for Bankruptcy